CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-27

Mucus Permeating Nanoparticulate Drug Delivery Systems

Ziel

The objective of the ALEXANDER project is the identification of novel strategies (e.g. proteolytic enzyme strategy, thiomer strategy, zeta potential changing systems, SNEDDS strategy) and the optimization of existing strategies (e.g. disulfide breaking strategy and slippery surface strategy) for the efficient transport of nanocarriers through the mucus gel layer (e.g. intestinal, nasal, ocular, vaginal, buccal, pulmonary). In particular, R&D activities will be focused on the synthesis of functionalized nanocarriers capable of permeating the mucus gel layer and delivering their therapeutic payload to the epithelium. The nanocarriers will be characterized with respect to their physicochemical properties, ability to cross the mucus gel layer, in vitro and in vivo cytotoxicity. The potential of the developed nanocarriers as delivery systems for mucosal administration of macromolecules will be demonstrated via the oral delivery of peptides, oligosaccharides and oligonucleotides and the nasal delivery of a plasmid encoding for an antigen.

Aufforderung zur Vorschlagseinreichung

FP7-NMP-2011-LARGE-5
Andere Projekte für diesen Aufruf anzeigen

Koordinator

DECHEMA GESELLSCHAFT FUR CHEMISCHETECHNIK UND BIOTECHNOLOGIE
EU-Beitrag
€ 1 015 908,63
Adresse
THEODOR HEUSS ALLEE 25
60486 Frankfurt
Deutschland

Auf der Karte ansehen

Region
Hessen Darmstadt Frankfurt am Main, Kreisfreie Stadt
Aktivitätstyp
Research Organisations
Kontakt Verwaltung
Andreas Förster (Dr.)
Links
Gesamtkosten
Keine Daten

Beteiligte (18)